Theralase Technologies Inc. (TLT) — Capital Reinvestment Ratio
Theralase Technologies Inc. (TLT) has a Capital Reinvestment Ratio of 0.05x as of September 2018, meaning it reinvests 0% of its operating cash flow (CA$436.21K) in capital expenditures (CA$19.98K). Check tangible equity quality of Theralase Technologies Inc. to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Theralase Technologies Inc. Capital Reinvestment Ratio (2005–2005)
This chart tracks Theralase Technologies Inc.'s Capital Reinvestment Ratio across 1 annual periods. For the full cash flow conversion analysis, see Theralase Technologies Inc. cash conversion from operations.
Annual Capital Reinvestment Ratio for Theralase Technologies Inc. (2005–2005)
Year-by-year Capital Reinvestment Ratio for Theralase Technologies Inc. from 2005 to 2005. See TLT cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (CAD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2005 | 1.00x | CA$85.33K | CA$85.30K | — |